US OKs new Merck drug for rare skin cancer Reuters.uk - By Lisa Richwine. WASHINGTON (Reuters) - Merck & Co Inc. won US approval for a new drug to treat a rare and slow-growing skin cancer, health officials said on Friday.

AP - A Johnson & Johnson drug received expanded federal approval Friday to treat aggression and other symptoms of autism in children.

Genetic mutation doubles breast cancer risk -study Reuters.uk - WASHINGTON (Reuters) - British researchers said they had found a new genetic mutation that doubled the risk of breast cancer in women who carry it.